Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 23444965)

1.

Effect of emulin on blood glucose in type 2 diabetics.

Ahrens MJ, Thompson DL.

J Med Food. 2013 Mar;16(3):211-5. doi: 10.1089/jmf.2012.0069. Epub 2013 Feb 27.

PMID:
23444965
2.

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46. doi: 10.1530/EJE-07-0500. Erratum in: Eur J Endocrinol. 2011 Nov;165(5):831.

3.

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

Diabetes Care. 2000 Nov;23(11):1660-5.

5.

The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus.

Garcia-Soria G, Gonzalez-Galvez G, Argoud GM, Gerstman M, Littlejohn TW 3rd, Schwartz SL, O'Farrell AM, Li X, Cherrington JM, Bennett C, Guler HP.

Diabetes Obes Metab. 2008 Apr;10(4):293-300. doi: 10.1111/j.1463-1326.2008.00868.x.

PMID:
18333888
6.

The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes.

Chiasson JL, Naditch L; Miglitol Canadian University Investigator Group.

Diabetes Care. 2001 Jun;24(6):989-94.

PMID:
11375358
7.

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.

DeFronzo RA, Hissa MN, Garber AJ, Luiz Gross J, Yuyan Duan R, Ravichandran S, Chen RS; Saxagliptin 014 Study Group.

Diabetes Care. 2009 Sep;32(9):1649-55. doi: 10.2337/dc08-1984. Epub 2009 May 28.

8.

Pioglitazone and reductions in post-challenge glucose levels in patients with type 2 diabetes.

Khan M, Murray FT, Karunaratne M, Perez A.

Diabetes Obes Metab. 2006 Jan;8(1):31-8.

PMID:
16367880
9.

Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients.

Pirags V, Lebovitz H, Fouqueray P.

Diabetes Obes Metab. 2012 Sep;14(9):852-8. doi: 10.1111/j.1463-1326.2012.01611.x. Epub 2012 May 16.

PMID:
22519919
13.

Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats.

Arag√£o DM, Guarize L, Lanini J, da Costa JC, Garcia RM, Scio E.

J Ethnopharmacol. 2010 Apr 21;128(3):629-33. doi: 10.1016/j.jep.2010.01.008. Epub 2010 Jan 11.

PMID:
20064597
14.

Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.

Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.

Clin Ther. 2008 May;30(5):858-67. doi: 10.1016/j.clinthera.2008.05.004.

PMID:
18555933
15.

A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.

Erle G, Lovise S, Stocchiero C, Lora L, Coppini A, Marchetti P, Merante D.

Acta Diabetol. 1999 Jun;36(1-2):61-5.

PMID:
10436254
17.

Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.

Rosenstock J, Brown A, Fischer J, Jain A, Littlejohn T, Nadeau D, Sussman A, Taylor T, Krol A, Magner J.

Diabetes Care. 1998 Dec;21(12):2050-5.

PMID:
9839093
18.
19.
20.

Miglitol combined with metformin improves glycaemic control in type 2 diabetes.

Van Gaal L, Maislos M, Schernthaner G, Rybka J, Segal P.

Diabetes Obes Metab. 2001 Oct;3(5):326-31.

PMID:
11703422
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk